Timolol Maleate

马来酸噻吗洛尔

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameTimolol Maleate
Drug Alias NameDextimolol Maleate噻马洛尔添慕宁酸梯莫洛锭缩苹果酸第莫洛 +[24] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsWounds and InjuriesHypertensionMyocardial Infarction +[8] 
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucomaOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1978/08/17
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesAuson Pharmaceuticals IncIcahn School Of Medicine At Mount SinaiBausch Health Companies Inc +[5] 
Inactive CompaniesMerck & Co Inc
Active IndicationsWounds and InjuriesGlaucoma, Open-AngleGlaucoma +[5] 
Inactive IndicationsHypertensionMyocardial InfarctionMigraine Disorders

Other Information

ATC CodeC07AA06S01ED01
Related LinksWikipediaDrugBankKEGG